Course Syllabus |
Course Name |
Translating Medical Patent Documents (E-J, J-E) |
Category |
Expert Competence |
Year Taken |
First or Second Year |
Offered Major/ Type of Course |
Major 3 / Elective |
No. of Credit |
2 |
Number of Classes |
16 |
Professor |
Hiroyuki Usuki
Professor Profile:
Graduated Tokyo Agricultural University Department of Agriculture (majored in Zymology) in 1964. Worked at Chugai Pharmaceutical Co., Ltd. Had charged filing foreign patent application at the Patent Department of Chugai for 15 years. Engaged in research and development of diagnostic products, and post-marketing surveillance of new drug for further 15 years and more in Chugai (1964-2003). Worked at US Drug Information Association Inc. (2003-2007). Experienced Vice Chairman and member of committees of Federation of Pharmaceutical Manufacturers’ Association and others. Worked as a freelance translator specializing in Chemistry, Pharmaceutical, Medical, and Biology since 2007. Involved in distance education and training at Babel University Professional School of Translation since 2011. |
Course Summary |
Translate Japanese into English and vice versa using case studies with sample chemical patent specifications and particular emphasis in pharmaceuticals.
|
How this course was developed |
This course was established as one of the multiple courses on patent translation
as Babel University created the current Patent, Technical, and Medical
Translation Major, itself based on the former Technical and Scientific
Translation Major. Babel University commissioned the development of this
course to Mr. Hiroshi Usuki, who has extensive experience in patent application
in the Patent Sector of Chugai Pharmaceutical Co. Professor Usuki developed
the course after detailed discussions with Babel University. The course
was first made available in 2011. |
Course Objective |
Have students obtain skills and know-how of medical/ pharmaceutical translation
both in EJ and JE, by repeating case studies on patent application documents
in mainly pharmaceutical field. While there are guidelines for writing
patent specifications, due to the convention of technical area in question,
historical background of the application, and preference of applicant,
there are various formats. Each case always contains particular items (objective,
construction, and effect), which specify the applied patent. |
Leaning Outcome |
Students who have successfully completed this course will be able to acquire
and establish skills and know-how to translating patent documents in the
medical/pharmaceutical field. |
Course Progression |
1. Read the textbook 2. Listen to audio lecture and gain a better understanding of the core material and lecture notes 3. Submit assignment and check degree of acquisition 4. Use the Q&A for any queries |
Deliverable (Course Text, etc) |
BABEL original textbook
*Authored originally by the Professor. Copyrighted by Babel University Professional School of Translation.
*Revised in November 2012 |
Course Outline |
 Lecture |
Description |
Lecture 1 |
Basic Knowledge Essential knowledge for patent translation |
Lecture 2 |
Case Study: Food Iron Fortified Cereal <EJ> |
Lecture 3 |
Case Study: Food Instant Coffee <EJ> |
Lecture 4 |
Case Study: Cosmetics Skin Whitening Agent (cosmetic for skin whitening) <JE> |
Lecture 5 |
Case Study: Cosmetics Non-Stain Lipstick <EJ> |
Lecture 6 |
Case Study: Medical Nicorandil (Sigmart: Chugai Pharmaceutical Co., Ltd.) <JE> |
Lecture 7 |
Case Study: Medica l Diazepam (Barium: Roche) <EJ> |
Lecture 8 |
Case Study: Medica l Famotidine (Gaster: Yamanouchi Pharmaceutical Co., Ltd.) <JE> |
Lecture 9 |
Case Study: Medica l Amlodipine (Norvasc: Pfizer) <EJ> |
Lecture 10 |
Case Study: Medica l Josamycin (Yamanouchi Pharmaceutical Co., Ltd.) <JE> |
Lecture 11 |
Case Study: Medica l Antihypertensive Pharmaceutic Adjuvant (Novartis) <EJ> |
Lecture 12 |
Case Study: Medica l Hyaluronic Acid (Suvenyl: DENKI KAGAKU KOGYO) <JE> |
Lecture 13 |
Case Study: Medica l Leuprorelin (Leuprorelin: Takeda Pharmaceutical Co., Ltd.) <JE> |
Lecture 14 |
Case Study: Medica l Diagnostic Remedy (PSA: Res.Corp) <EJ> |
Lecture 15 |
Case Study: Medica l Erythropoietin (Espo: KIRIN-AMGEN, INC.) <EJ> |
Lecture 16 |
Case Study: Medica l Tocilizumab (Actemra: Chugai Pharmaceutical Co., Ltd.) <JE> |
|
Grade Evaluation and Course Requirement |
1. Assignments (All assignments must be submitted)
2. Final Exam (Minimum Course Requirement: B or above)
Grade |
Score |
A |
85 - 100 |
B |
70 - 84 |
C |
60 - 69 |
D |
50 - 59 |
F |
49 and under |
Submission papers will be returned with the evaluation sheet, which states evaluation marking and comments as well as corrections with rubrics.
|
 |